Media playback is unsupported on your device

Breast cancer drug Kadcyla price reduction urged

23 April 2014 Last updated at 18:43 BST

The medicines watchdog for England and Wales says it is disappointed that the drug company Roche will not reduce the price of a new breast cancer drug for the NHS.

NICE says the drug, Kadcyla, is too expensive at more than £90,000 a year per patient. The drug can add months to the life of women dying of breast cancer.

Dominic Hughes reports.

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.